These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32776697)

  • 1. Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome.
    Donkervoort S; Mohassel P; Laugwitz L; Zaki MS; Kamsteeg EJ; Maroofian R; Chao KR; Verschuuren-Bemelmans CC; Horber V; Fock AJM; McCarty RM; Jain MS; Biancavilla V; McMacken G; Nalls M; Voermans NC; Elbendary HM; Snyder M; Cai C; Lehky TJ; Stanley V; Iannaccone ST; Foley AR; Lochmüller H; Gleeson J; Houlden H; Haack TB; Horvath R; Bönnemann CG
    Am J Med Genet A; 2020 Oct; 182(10):2272-2283. PubMed ID: 32776697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant and recessive congenital myasthenic syndromes caused by SYT2 mutations.
    Maselli RA; Wei DT; Hodgson TS; Sampson JB; Vazquez J; Smith HL; Pytel P; Ferns M
    Muscle Nerve; 2021 Aug; 64(2):219-224. PubMed ID: 34037996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recessive congenital myasthenic syndrome caused by a homozygous mutation in SYT2 altering a highly conserved C-terminal amino acid sequence.
    Maselli RA; van der Linden H; Ferns M
    Am J Med Genet A; 2020 Jul; 182(7):1744-1749. PubMed ID: 32250532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
    Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
    Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new de novo SYT2 mutation presenting as distal weakness. Neuropathy or neuromuscular junction dysfunction?
    Fionda L; Turon-Sans J; Fuentes Prior P; Bernal Noguera S; Cortés-Vicente E; López-Pérez MA; Gallardo E; Rojas-García R
    J Peripher Nerv Syst; 2021 Mar; 26(1):113-117. PubMed ID: 33320396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Spot Congenital Myasthenic Syndromes Resembling the Lambert-Eaton Myasthenic Syndrome? A Brief Review of Clinical, Electrophysiological, and Genetics Features.
    Lorenzoni PJ; Scola RH; Kay CSK; Werneck LC; Horvath R; Lochmüller H
    Neuromolecular Med; 2018 Jun; 20(2):205-214. PubMed ID: 29696584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.
    Whittaker RG; Herrmann DN; Bansagi B; Hasan BA; Lofra RM; Logigian EL; Sowden JE; Almodovar JL; Littleton JT; Zuchner S; Horvath R; Lochmüller H
    Neurology; 2015 Dec; 85(22):1964-71. PubMed ID: 26519543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New recessive mutations in
    Bauché S; Sureau A; Sternberg D; Rendu J; Buon C; Messéant J; Boëx M; Furling D; Fauré J; Latypova X; Gelot AB; Mayer M; Mary P; Whalen S; Fournier E; Cloix I; Remerand G; Laffargue F; Nougues MC; Fontaine B; Eymard B; Isapof A; Strochlic L
    Neurol Genet; 2020 Dec; 6(6):e534. PubMed ID: 33659639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea.
    Bauché S; O'Regan S; Azuma Y; Laffargue F; McMacken G; Sternberg D; Brochier G; Buon C; Bouzidi N; Topf A; Lacène E; Remerand G; Beaufrere AM; Pebrel-Richard C; Thevenon J; El Chehadeh-Djebbar S; Faivre L; Duffourd Y; Ricci F; Mongini T; Fiorillo C; Astrea G; Burloiu CM; Butoianu N; Sandu C; Servais L; Bonne G; Nelson I; Desguerre I; Nougues MC; Bœuf B; Romero N; Laporte J; Boland A; Lechner D; Deleuze JF; Fontaine B; Strochlic L; Lochmuller H; Eymard B; Mayer M; Nicole S
    Am J Hum Genet; 2016 Sep; 99(3):753-761. PubMed ID: 27569547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy.
    Herrmann DN; Horvath R; Sowden JE; Gonzalez M; Sanchez-Mejias A; Guan Z; Whittaker RG; Almodovar JL; Lane M; Bansagi B; Pyle A; Boczonadi V; Lochmüller H; Griffin H; Chinnery PF; Lloyd TE; Littleton JT; Zuchner S
    Am J Hum Genet; 2014 Sep; 95(3):332-9. PubMed ID: 25192047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome.
    Salpietro V; Lin W; Delle Vedove A; Storbeck M; Liu Y; Efthymiou S; Manole A; Wiethoff S; Ye Q; Saggar A; McElreavey K; Krishnakumar SS; ; Pitt M; Bello OD; Rothman JE; Basel-Vanagaite L; Hubshman MW; Aharoni S; Manzur AY; Wirth B; Houlden H
    Ann Neurol; 2017 Apr; 81(4):597-603. PubMed ID: 28253535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
    Rodríguez Cruz PM; Palace J; Beeson D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome.
    O'Connor E; Töpf A; Müller JS; Cox D; Evangelista T; Colomer J; Abicht A; Senderek J; Hasselmann O; Yaramis A; Laval SH; Lochmüller H
    Brain; 2016 Aug; 139(Pt 8):2143-53. PubMed ID: 27259756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Clinical Phenotypes in Congenital Myasthenic Syndrome Associated with the c.1327delG Frameshift Mutation in CHRNE Encoding the Acetylcholine Receptor Epsilon Subunit.
    Kastreva K; Chamova T; Blagoeva S; Bichev S; Mihaylova V; Meyer S; Thompson R; Cherninkova S; Guergueltcheva V; Lochmuller H; Tournev I
    J Neuromuscul Dis; 2024; 11(5):1011-1020. PubMed ID: 38995797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
    Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
    Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the genetic and phenotypic spectrum of congenital myasthenic syndrome: new homozygous VAMP1 splicing variants in 2 novel individuals.
    Cotrina-Vinagre FJ; Rodríguez-García ME; Del Pozo-Filíu L; Hernández-Laín A; Arteche-López A; Morte B; Sevilla M; Pérez-Jurado LA; Quijada-Fraile P; Camacho A; Martínez-Azorín F
    J Hum Genet; 2024 May; 69(5):187-196. PubMed ID: 38355957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital myasthenic syndrome due to a novel missense mutation in the gene encoding choline acetyltransferase.
    Schmidt C; Abicht A; Krampfl K; Voss W; Stucka R; Mildner G; Petrova S; Schara U; Mortier W; Bufler J; Huebner A; Lochmüller H
    Neuromuscul Disord; 2003 Mar; 13(3):245-51. PubMed ID: 12609506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrostigmine therapy in a patient with VAMP1-related congenital myasthenic syndrome.
    Al-Muhaizea MA; AlQuait L; AlRasheed A; AlHarbi S; Albader AA; AlMass R; Albakheet A; Alhumaidan A; AlRasheed MM; Colak D; Kaya N
    Neuromuscul Disord; 2020 Jul; 30(7):611-615. PubMed ID: 32616363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort.
    Polavarapu K; Sunitha B; Töpf A; Preethish-Kumar V; Thompson R; Vengalil S; Nashi S; Bardhan M; Sanka SB; Huddar A; Unnikrishnan G; Arunachal G; Girija MS; Porter A; Azuma Y; Lorenzoni PJ; Baskar D; Anjanappa RM; Keertipriya M; Padmanabh H; Harikrishna GV; Laurie S; Matalonga L; Horvath R; Nalini A; Lochmüller H
    Brain; 2024 Jan; 147(1):281-296. PubMed ID: 37721175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.